O'Malley Brendan M. 4
4 · ABEONA THERAPEUTICS INC. · Filed Jun 9, 2026
Research Summary
AI-generated summary of this filing
Abeona Therapeutics (ABEO) SVP Brendan O'Malley Sells Shares
What Happened
Brendan M. O'Malley, Senior Vice President and Chief Legal Officer of Abeona Therapeutics (ABEO), sold a total of 11,131 shares in open-market transactions on June 8–9, 2026. He disposed of 4,826 shares at a weighted average price of $5.43 (proceeds $26,203) and 6,305 shares at a weighted average price of $5.30 (proceeds $33,443), for combined proceeds of approximately $59,646. These were sales (not purchases) reported on Form 4.
Key Details
- Dates and prices:
- 2026-06-08: 4,826 shares sold @ weighted avg $5.43 (total ~$26,203). Price range reported: $5.345–$5.54. (Footnote F2)
- 2026-06-09: 6,305 shares sold @ weighted avg $5.30 (total ~$33,443). Price range reported: $5.24–$5.47. (Footnote F3)
- Total shares sold: 11,131; total proceeds: ~$59,646.
- Reason: Footnote F1 states the sales were to cover tax obligations associated with the vesting of restricted stock awards (tax withholding).
- Filing/timeliness: The Form 4 was filed on 2026-06-09 reporting transactions on 2026-06-08 and 06-09; the filing does not indicate lateness.
- Shares owned after transaction: Not specified in the information provided on the filing.
- Transaction code: S = sale.
Context
These sales were made to satisfy tax withholding on vested restricted stock awards, a common and routine administrative transaction for executives. Such tax-related sales do not necessarily indicate a change in the insider’s view of the company.
Insider Transaction Report
- Sale
Common Stock
[F1][F2]2026-06-08$5.43/sh−4,826$26,203→ 446,308 total - Sale
Common Stock
[F1][F3]2026-06-09$5.30/sh−6,305$33,443→ 440,003 total
Footnotes (3)
- [F1]The sale reported in this Form 4 was to cover tax obligations associated with the vesting of restricted stock awards.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.345 to $5.54 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.24 to $5.47 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.